Neil E. Fleshner serves as Executive at POINT Biopharma Global Inc., where they oversee executive responsibilities. Since joining the company, Neil E. Fleshner has executed 8 insider transactions totaling $4.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 22, 2023 involved transacting 233,171 shares valued at $0.
Neil E. Fleshner currently holds 2,773,045 shares of POINT Biopharma Global Inc. (PNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil E. Fleshner has been a net seller of PNT stock. They have purchased $0 and sold $4.2M worth of shares.
Neil E. Fleshner's most recent insider trade was on Dec 22, 2023, when they sold 233,171 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 22, 2023 | PNT | $0 | Tender | 2,773,045 | $N/A | Discretionary |
| Oct 31, 2023 | PNT | $0 | Gift | 250,000 | $N/A | Discretionary |
| May 25, 2022 | PNT | $4.2M | Sale | 564,204 | $7.51 | Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 3,587,249 | $N/A | Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 358 | $N/A | Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 233,171 | $N/A | Discretionary |